Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuya Ishii

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
BMC Genomics|April 1, 2009
A signature-based method for indexing cell cycle phase distribution from microarray profilesHideaki Mizuno, Yoshito Nakanishi, Nobuya Ishii, et al.
Microbiology (Reading, England)|February 1, 1997
Biochemical and genetic characterization of Rbf1p, a putative transcription factor of Candida albicansNobuya Ishii, Mutumi Yamamoto, Fumie Yoshihara, et al.
Cancer Science|September 4, 2012
Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-DKenji Kashima, Miho Watanabe, Yasuko Satoh, et al.
Cancer Science|August 27, 2014
Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4Kenji Kashima, Miho Watanabe, Yasuko Sato, et al.
The Prostate|November 11, 2009
Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10Nobuyuki Ishikura, Hiromitsu Kawata, Ayako Nishimoto, et al.
Yeast (Chichester, England)|January 28, 2004
Isolation and characterization of Candida albicans homologue of RAP1, a repressor and activator protein gene in Saccharomyces cerevisiaeHiroshi Uemura, Miyuki Watanabe-Yoshida, Nobuya Ishii, et al.
Molecular Cancer Therapeutics|January 16, 2015
Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, et al.
Microbiology (Reading, England)|February 1, 1997
A DNA-binding protein from Candida albicans that binds to the RPG box of Saccharomyces cerevisiae and the telomeric repeat sequence of C. albicansNobuya Ishii, Mutumi Yamamoto, Hans-Werner Lahm, et al.
Molecular Cancer Therapeutics|October 7, 2015
ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR InhibitorYoshito Nakanishi, Hideaki Mizuno, Hitoshi Sase, et al.
EJNMMI Research|September 18, 2013
[18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft modelsTetyana Tegnebratt, Li Lu, Lucy Lee, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
BMC Genomics|April 1, 2009
A signature-based method for indexing cell cycle phase distribution from microarray profilesHideaki Mizuno, Yoshito Nakanishi, Nobuya Ishii, et al.
Microbiology (Reading, England)|February 1, 1997
Biochemical and genetic characterization of Rbf1p, a putative transcription factor of Candida albicansNobuya Ishii, Mutumi Yamamoto, Fumie Yoshihara, et al.
Cancer Science|September 4, 2012
Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-DKenji Kashima, Miho Watanabe, Yasuko Satoh, et al.
Cancer Science|August 27, 2014
Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4Kenji Kashima, Miho Watanabe, Yasuko Sato, et al.
The Prostate|November 11, 2009
Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10Nobuyuki Ishikura, Hiromitsu Kawata, Ayako Nishimoto, et al.
Yeast (Chichester, England)|January 28, 2004
Isolation and characterization of Candida albicans homologue of RAP1, a repressor and activator protein gene in Saccharomyces cerevisiaeHiroshi Uemura, Miyuki Watanabe-Yoshida, Nobuya Ishii, et al.
Molecular Cancer Therapeutics|January 16, 2015
Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, et al.
Microbiology (Reading, England)|February 1, 1997
A DNA-binding protein from Candida albicans that binds to the RPG box of Saccharomyces cerevisiae and the telomeric repeat sequence of C. albicansNobuya Ishii, Mutumi Yamamoto, Hans-Werner Lahm, et al.
Molecular Cancer Therapeutics|October 7, 2015
ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR InhibitorYoshito Nakanishi, Hideaki Mizuno, Hitoshi Sase, et al.
EJNMMI Research|September 18, 2013
[18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft modelsTetyana Tegnebratt, Li Lu, Lucy Lee, et al.
Pageof 4